Etiket: PfizerBioNTech
Health Canada authorizes updated Pfizer-BioNTech COVID-19 vaccine
Health Canada has authorized the updated Pfizer-BioNTech COVID-19 vaccine for people six months and older. The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada. This is…
Moderna sues Pfizer-BioNTech for patent infringement over their messenger RNA vaccine
Moderna Believes Pfizer and BioNTech’s Covid-19 Vaccine Infringes Patents ‘Covers Fundamental Messenger RNA Technology’” filed by Moderna between 2010 and 2016. Article written by Published on 08/26/2022 14:51 Update on…
the stakes of Moderna’s complaint against Pfizer-BioNTech for patent infringement
The American laboratory Moderna launched a major legal battle against Pfizer and BioNTech on Friday August 26, accusing them of having infringed patents on technologies essential to its messenger RNA…
COVID-19 vaccine | Moderna sues Pfizer-BioNTech for patent infringement
(Washington) The American biotechnology company Moderna announced Friday to file a complaint against Pfizer and BioNTech for patent infringement concerning their messenger RNA vaccine against COVID-19. Posted at 8:58 Updated…
Moderna sues Pfizer-BioNTech for patent infringement over their messenger RNA vaccine
Moderna Believes Pfizer and BioNTech’s Covid-19 Vaccine Infringes Patents ‘Covers Fundamental Messenger RNA Technology’” filed by Moderna between 2010 and 2016. Article written by Published on 08/26/2022 14:51 Update on…
Pfizer-BioNTech launches clinical trial of vaccine against Omicron
(Washington) The Pfizer-BioNTech alliance has started recruiting for a clinical trial which aims to test, on adults aged 55 and under, the safety and immune response of their vaccine against…
Clinical trial of a vaccine against Omicron begins for Pfizer-BioNTech
The Pfizer-BioNTech alliance has started recruiting for a clinical trial which aims to test, on adults aged 55 and under, the safety and immune response of their vaccine against COVID-19…
US clears Pfizer-BioNTech vaccine recall for 12-15 year olds
This decision comes amid the outbreak of the epidemic in the country, linked to the Omicron variant. Article written by Posted the 01/03/2022 17:17 Update the 03/01/2022 17:30 Reading time…
US clears Pfizer-BioNTech vaccine recall for 12-15 year olds
This decision comes amid the outbreak of the epidemic in the country, linked to the Omicron variant. Article written by Posted the 01/03/2022 17:17 Update the 01/03/2022 17:22 Reading time…
Pfizer-BioNTech believes that efficacy against Omicron variant is “improved with third dose”
Both groups promise that their vaccine is “still effective” against the new strain of the virus while developing a “specific” product whose marketing could begin by March 2022. Article written…
Pfizer-BioNTech believes that efficacy against Omicron variant is “improved with third dose”
Both groups promise that their vaccine is “still effective” against the new strain of the virus while developing a “specific” product whose marketing could begin by March 2022. Article written…
Pfizer-BioNTech vaccine | “Still effective” against the Omicron variant after three doses
(Berlin) The COVID-19 vaccine developed by the companies Pfizer and BioNTech is “still effective” after “three doses” against the Omicron variant of the virus, the laboratories said on Wednesday, which…
Vaccination for 5-11 year olds | Health Canada approves Pfizer-BioNTech vaccine
(Ottawa) The benefits of Pfizer-BioNTech’s vaccine for children outweigh the risks, according to Health Canada. Vaccination can therefore begin quickly in Quebec. It is a matter of days, according to…
Health Canada authorizes vaccination of children aged 5 to 11 with Pfizer-BioNTech vaccine
It is now official, Health Canada is authorizing the use of the children’s version of the Pfizer-BioNTech vaccine. The federal government has already delivered 2.9 million doses for children aged…
Pfizer-BioNTech vaccine | The booster dose allowed for all adults
(Ottawa) Health Canada approves Pfizer-BioNTech booster vaccine for those 18 years of age and older. Posted on November 9, 2021 at 12:31 p.m. Melanie Marquis Press The green light from…
Pfizer-BioNTech vaccine for 5-11 year olds | The doses will arrive “very soon after” an approval.
Désolé, votre navigateur ne supporte pas les videos (Ottawa) « Si et quand » le vaccin pédiatrique de Pfizer-BioNTech est approuvé par Santé Canada, on recevra au pays près de 3 millions…
COVID-19: a 3rd dose of Pfizer-BioNTech vaccine 95.6% effective
A booster dose of the COVID-19 vaccine developed by the Pfizer-BioNTech alliance is 95.6% effective against symptomatic forms of the disease, according to a study by the two laboratories published…
Pfizer-BioNTech vaccine | A third dose effective at 95.6%
Sorry, your browser does not support videos (Frankfurt) A booster dose of the COVID-19 vaccine developed by the Pfizer-BioNTech alliance is 95.6% effective against symptomatic forms of the disease, according…